Oral vinorelbine in combination with cisplatin or carboplatinin adjuvant chemotherapy of non-small cell lung cancer: Aprospective multicentre study of feasibility, tolerability and3-year survival
2012
Adjuvant cisplatinum-based chemotherapy is recommended for
routine use in patients with stages IIA, IIB, and IIIA of non
small-cell lung cancer (NSCLC) after radical resection. Results
in stage IB were not conclusive. Vinorelbine is a preferable
associated drug in this indication and a randomized study
proved the comparable effectiveness and tolerability of
vinorelbine given both orally or intravenously (i.v.) in
advanced NSCLC, meanwhile oral vinorelbine gives better comfort
to patients.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI